Laurus Labs

LAURUSLABS · NSE · INR

1971,50 ₹Variación respecto al cierre anterior: −0,63 %Variación absoluta: −12,50 ₹

Cierre · 5 de octubre de 2026

Perfil de la empresa

Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs and solid oral drug products for intermediates for anti-retroviral (ARV), anti-diabetic, cardiovascular, anti-asthma, ophthalmology, oncology, and gastroenterology. It also develops and manufactures animal-origin-free recombinant proteins and cell-culture media supplements and research and development services, including drug substance development, drug product development, and biologics development. In addition, the company offers non-human ingredients; rare disease therapeutics; and finished dosages. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.

Descripción disponible en inglés.

Datos societarios

Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
País
India
Sede
Jubilee Hills, 500033, Hyderabad
Empleados
7.059
Cotización
LAURUSLABS · NSE
Divisa
INR